Cancer Therapeutic Approaches

Cancer biomarkers have many potential applications in cancer treatment, including screening, diagnosis, risk assessment, prediction of response to treatment, and monitoring of progression of disease. Metabolomics is growing in the field with particular attention to its application as a biomarker in cancer diagnosis. Biomarkers of disease could incorporate a wide scope of biochemical elements, for example, lipids, proteins, sugars, and little metabolites, nucleic acid, cytokinetic and cytogenetic parameters etc.

  • Cancer metabolomics and diagnostic biomarkers
  • Current metabolomic methodologies
  • Applications of metabolomics in oncology and biomarker discovery
  • Metabolite platform for robust validation of biomarkers
  • Metabolomics in pharmaceutical research
  • Cancer metabolism meets systems biology
  • Novel approaches to cancer therapeutics
  • Cell-based biomarkers for cancer immunotherapy discovery and development

Related Conference of Cancer Therapeutic Approaches

April 16-17, 2020

16th World Congress on Structural Biology

Amsterdam, Netherlands
April 20-21, 2020

11th Tissue Science and Regeneration Congress

Kualalumpur, Malaysia
June 28-30 2020

globalbiotechnology-cs-2020

June 28-30 2020

oilgas-cs-2020

June 28-30 2020

BEHAVIOURAL SCIENCE-2020

June 28-30 2020

Bioinfo 2020

May 10-11, 2020

26th World Nursing & Nurse Practitioner Conference

Yokohama, Japan
July 17-18, 2020

10th Glycobiology World Congress

Vienna, Austria
August 4-5, 2020

12th Euro Biosensors & Bioelectronics Congress

Zurich, Switzerland
September 28-29, 2020

2nd International Conference on Metabolomics, Genomics and Proteomics

Singapore City, Singapore
September 28-29, 2020

19th International Conference on Structural Biology

Barcelona, Spain
October 08-09, 2020

10th European Biosimilars Summit

Milan, Italy
October 14-15, 2020

9th World Congress on Glycobiology & Glycochemistry

Rome, Italy

Cancer Therapeutic Approaches Conference Speakers

Recommended Sessions

Related Journals

Are you interested in